Birdwatch Note
2025-08-19 16:27:59 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Ozempic has been approved in Canada since 2018. https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00388
Written by B97A4AC222103081F60B34D5C4563964D50D6C33ACB0E9DAF97A782FA92518C6
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1957797016303726834
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1957841988977586608
- noteId - 1957841988977586608
- participantId -
- noteAuthorParticipantId - B97A4AC222103081F60B34D5C4563964D50D6C33ACB0E9DAF97A782FA92518C6 Participant Details
- createdAtMillis - 1755620879774
- tweetId - 1957797016303726834
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ozempic has been approved in Canada since 2018. https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00388
Note Ratings
| rated at | rated by | |
| 2025-08-19 14:11:33 -0500 | Rating Details | |
| 2025-08-19 13:37:57 -0500 | Rating Details | |
| 2025-08-19 13:18:20 -0500 | Rating Details | |
| 2025-08-19 13:15:25 -0500 | Rating Details | |
| 2025-08-19 12:42:16 -0500 | Rating Details | |
| 2025-08-19 12:08:30 -0500 | Rating Details | |
| 2025-08-19 13:41:34 -0500 | Rating Details | |
| 2025-08-19 13:31:34 -0500 | Rating Details | |
| 2025-08-19 13:23:40 -0500 | Rating Details | |
| 2025-08-19 14:08:08 -0500 | Rating Details | |
| 2025-08-19 12:45:26 -0500 | Rating Details | |
| 2025-08-19 12:04:37 -0500 | Rating Details | |
| 2025-08-19 14:12:16 -0500 | Rating Details | |
| 2025-08-19 12:13:08 -0500 | Rating Details | |
| 2025-08-19 11:45:32 -0500 | Rating Details | |
| 2025-08-19 12:12:16 -0500 | Rating Details | |
| 2025-08-19 13:33:00 -0500 | Rating Details | |
| 2025-08-19 13:20:40 -0500 | Rating Details | |
| 2025-08-19 12:44:46 -0500 | Rating Details | |
| 2025-08-19 13:49:43 -0500 | Rating Details | |
| 2025-08-19 12:33:10 -0500 | Rating Details | |
| 2025-08-19 13:52:31 -0500 | Rating Details | |
| 2025-08-19 12:04:53 -0500 | Rating Details | |
| 2025-08-19 16:22:49 -0500 | Rating Details | |
| 2025-08-19 14:32:15 -0500 | Rating Details | |
| 2025-08-19 13:34:49 -0500 | Rating Details | |
| 2025-08-19 12:27:05 -0500 | Rating Details | |
| 2025-08-19 11:41:28 -0500 | Rating Details | |
| 2025-08-19 12:48:08 -0500 | Rating Details | |
| 2025-08-19 12:00:43 -0500 | Rating Details | |
| 2025-08-19 11:41:56 -0500 | Rating Details | |
| 2025-08-19 17:17:06 -0500 | Rating Details | |
| 2025-08-19 13:12:10 -0500 | Rating Details | |
| 2025-08-19 13:31:13 -0500 | Rating Details | |
| 2025-08-19 11:43:21 -0500 | Rating Details | |
| 2025-08-19 18:44:06 -0500 | Rating Details | |
| 2025-08-19 21:16:17 -0500 | Rating Details | |
| 2025-08-20 00:39:09 -0500 | Rating Details | |
| 2025-08-20 02:52:11 -0500 | Rating Details | |
| 2025-08-20 19:32:44 -0500 | Rating Details | |
| 2025-08-20 09:21:00 -0500 | Rating Details | |
| 2025-08-20 00:55:32 -0500 | Rating Details |